Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001851416-25-000004
Filing Date
2025-01-21
Accepted
2025-01-21 13:01:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7282
  Complete submission text file 0001851416-25-000004.txt   9051
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Subject) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90926 | Film No.: 25541557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 303 E WACKER DRIVE SUITE 1040 CHICAGO IL 60601
Business Address 303 E WACKER DRIVE SUITE 1040 CHICAGO IL 60601 312-297-7000
Streeterville Capital LLC (Filed by) CIK: 0001851416 (see all company filings)

EIN.: 852954598 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SCHEDULE 13G/A